334 related articles for article (PubMed ID: 35015767)
1. The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model.
Ahring KK; Dagnæs-Hansen F; Brüel A; Christensen M; Jensen E; Jensen TG; Johannsen M; Johansen KS; Lund AM; Madsen JG; Brøndum-Nielsen K; Pedersen M; Sørensen LK; Kjolby M; Møller LB
PLoS One; 2022; 17(1):e0261150. PubMed ID: 35015767
[TBL] [Abstract][Full Text] [Related]
2. Glycomacropeptide, a low-phenylalanine protein isolated from cheese whey, supports growth and attenuates metabolic stress in the murine model of phenylketonuria.
Solverson P; Murali SG; Brinkman AS; Nelson DW; Clayton MK; Yen CL; Ney DM
Am J Physiol Endocrinol Metab; 2012 Apr; 302(7):E885-95. PubMed ID: 22297302
[TBL] [Abstract][Full Text] [Related]
3. Low bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet.
Solverson P; Murali SG; Litscher SJ; Blank RD; Ney DM
PLoS One; 2012; 7(9):e45165. PubMed ID: 23028819
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Glycomacropeptide with Phenylalanine Free-Synthetic Amino Acids in Test Meals to PKU Patients: No Significant Differences in Biomarkers, Including Plasma Phe Levels.
Ahring KK; Lund AM; Jensen E; Jensen TG; Brøndum-Nielsen K; Pedersen M; Bardow A; Holst JJ; Rehfeld JF; Møller LB
J Nutr Metab; 2018; 2018():6352919. PubMed ID: 29511574
[TBL] [Abstract][Full Text] [Related]
5. Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU.
Daly A; Evans S; Chahal S; Santra S; Pinto A; Jackson R; Gingell C; Rocha J; Van Spronsen FJ; MacDonald A
Orphanet J Rare Dis; 2019 Feb; 14(1):44. PubMed ID: 30770754
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic brain modulation with targeted large neutral amino acid supplements in the Pah-enu2 phenylketonuria mouse model.
van Vliet D; Bruinenberg VM; Mazzola PN; van Faassen MH; de Blaauw P; Pascucci T; Puglisi-Allegra S; Kema IP; Heiner-Fokkema MR; van der Zee EA; van Spronsen FJ
Am J Clin Nutr; 2016 Nov; 104(5):1292-1300. PubMed ID: 27655443
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Glycomacropeptide versus Amino Acids on Phenylalanine and Tyrosine Variability over 24 Hours in Children with PKU: A Randomized Controlled Trial.
Daly A; Evans S; Chahal S; Santra S; Pinto A; Gingell C; Rocha JC; van Spronsen F; Jackson R; MacDonald A
Nutrients; 2019 Feb; 11(3):. PubMed ID: 30823411
[No Abstract] [Full Text] [Related]
8. Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control?
Daly A; Evans S; Chahal S; Santra S; MacDonald A
J Hum Nutr Diet; 2017 Aug; 30(4):515-523. PubMed ID: 28111827
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of low-phenylalanine protein sources on brain neurotransmitters and behavior in C57Bl/6-Pah(enu2) mice.
Sawin EA; Murali SG; Ney DM
Mol Genet Metab; 2014 Apr; 111(4):452-61. PubMed ID: 24560888
[TBL] [Abstract][Full Text] [Related]
10. Large Neutral Amino Acid Supplementation Exerts Its Effect through Three Synergistic Mechanisms: Proof of Principle in Phenylketonuria Mice.
van Vliet D; Bruinenberg VM; Mazzola PN; van Faassen MH; de Blaauw P; Kema IP; Heiner-Fokkema MR; van Anholt RD; van der Zee EA; van Spronsen FJ
PLoS One; 2015; 10(12):e0143833. PubMed ID: 26624009
[TBL] [Abstract][Full Text] [Related]
11. Large Neutral Amino Acid Therapy Increases Tyrosine Levels in Adult Patients with Phenylketonuria: A Long-Term Study.
Burlina AP; Cazzorla C; Massa P; Polo G; Loro C; Gueraldi D; Burlina AB
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31640267
[TBL] [Abstract][Full Text] [Related]
12. Dietary glycomacropeptide supports growth and reduces the concentrations of phenylalanine in plasma and brain in a murine model of phenylketonuria.
Ney DM; Hull AK; van Calcar SC; Liu X; Etzel MR
J Nutr; 2008 Feb; 138(2):316-22. PubMed ID: 18203898
[TBL] [Abstract][Full Text] [Related]
13. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study.
Schindeler S; Ghosh-Jerath S; Thompson S; Rocca A; Joy P; Kemp A; Rae C; Green K; Wilcken B; Christodoulou J
Mol Genet Metab; 2007 May; 91(1):48-54. PubMed ID: 17368065
[TBL] [Abstract][Full Text] [Related]
14. Preliminary Investigation to Review If a Glycomacropeptide Compared to L-Amino Acid Protein Substitute Alters the Pre- and Postprandial Amino Acid Profile in Children with Phenylketonuria.
Daly A; Evans S; Pinto A; Jackson R; Ashmore C; Rocha JC; MacDonald A
Nutrients; 2020 Aug; 12(8):. PubMed ID: 32823853
[TBL] [Abstract][Full Text] [Related]
15. Advances in the nutritional and pharmacological management of phenylketonuria.
Ney DM; Blank RD; Hansen KE
Curr Opin Clin Nutr Metab Care; 2014 Jan; 17(1):61-8. PubMed ID: 24136088
[TBL] [Abstract][Full Text] [Related]
16. Long-term dietary intervention with low Phe and/or a specific nutrient combination improve certain aspects of brain functioning in phenylketonuria (PKU).
Bruinenberg VM; van Vliet D; van der Goot E; Counotte DS; Kuhn M; van Spronsen FJ; van der Zee EA
PLoS One; 2019; 14(3):e0213391. PubMed ID: 30875376
[TBL] [Abstract][Full Text] [Related]
17. Future role of large neutral amino acids in transport of phenylalanine into the brain.
Matalon R; Surendran S; Matalon KM; Tyring S; Quast M; Jinga W; Ezell E; Szucs S
Pediatrics; 2003 Dec; 112(6 Pt 2):1570-4. PubMed ID: 14654667
[TBL] [Abstract][Full Text] [Related]
18. Casein Glycomacropeptide: An Alternative Protein Substitute in Tyrosinemia Type I.
Daly A; Evans S; Pinto A; Ashmore C; MacDonald A
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579102
[TBL] [Abstract][Full Text] [Related]
19. Investigation of paediatric PKU breath malodour, comparing glycomacropeptide with phenylalanine free L-amino acid supplements.
Tiele A; Daly A; Hattersley J; Pinto A; Evans S; Ashmore C; MacDonald A; Covington JA
J Breath Res; 2019 Oct; 14(1):016001. PubMed ID: 31476741
[TBL] [Abstract][Full Text] [Related]
20. Casein glycomacropeptide in phenylketonuria: does it bring clinical benefit?
Daly A; Ilgaz F; Pinto A; MacDonald A
Curr Opin Clin Nutr Metab Care; 2024 Jan; 27(1):31-39. PubMed ID: 38085662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
